Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Post-marketing Observational Study to Evaluate the Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over

NCT02321449 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT02321449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02321449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Post-marketing Observational Study to Evaluate the Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
June 30, 2014
Completion date
February 28, 2015
Enrollment
40 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia